Innovation MESH Network | Mass General Brigham

Asset 5
Sign in Sign up

  • Home
  • Courses
  • Find-an-Innovator
  • Grand Rounds
  • Innovation Funding
    • Internal
    • External
  • Instructors
  • About
Sign in Sign up
logo nomgb SMALL
  • Home
  • Courses
  • Find-an-Innovator
  • Grand Rounds
  • Innovation Funding
    • Internal
    • External
  • Instructors
  • About

Course Tag: COVID-19

Mass General Brigham Innovation MESH Core

MGB Innovation MESH Core: Healthcare Innovation Bootcamp is the official innovation course of Mass General Brigham. This award-winnin…

A la carte: Technology Solutions Now and in the Future (WMIF)

Experts leading large teams at the epicenter of the coronavirus outbreak discuss how technology is shaping the pandemic response today and in the coming years.…

A la carte: The Fundamentals of Digital Health (MESH CORE)

Digital health is increasingly prevalent in every aspect of healthcare today. While a valuable player during COVID-19, infrastructure to support digit…

A la carte: BIOGEN CEO: Keeping Priority on the Biggest Diseases (WMIF)

Biogen CEO Michel Vounatsos will discuss how Biogen is tackling some of society’s most devastating neurological and neurodegenerative disorders, and share his perspective on the…

Contact Info

Mass General Brigham Innovation

innovation.massgeneralbrigham.org

One Main Street, Suite 501
Cambridge, MA 02142

Twitter
Register Now!
Contact Info

MESH Incubator, Mass General Brigham

meshincubator.org

55 Fruit Street, Blake 258,
Boston, MA 02114

617-726-2000

hello@meshincubator.org

Twitter
Register Now!
Copyright © 2023 Innovation MESH Network | Mass General Brigham INCORPORATED. ALL RIGHTS RESERVED.

Disclaimer   Privacy Policy

Forum Description

Biogen CEO Michel Vounatsos will discuss how Biogen is tackling some of society’s most devastating neurological and neurodegenerative disorders, and share his perspective on the impact the global COVID-19 pandemic is having on the biopharmaceutical industry. Moderator: Jean-François Formela, MD, Partner, Atlas Venture Michel Vounatsos, CEO, Biogen

Report

There was a problem reporting this post.

Harassment or bullying behavior
Contains mature or sensitive content
Contains misleading or false information
Contains abusive or derogatory content
Contains spam, fake content or potential malware

Block Member?

Please confirm you want to block this member.

You will no longer be able to:

  • See blocked member's posts
  • Mention this member in posts
  • Invite this member to groups
  • Message this member
  • Add this member as a connection

Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.

Report

You have already reported this .
Clear Clear All